Cibc Private Wealth Group, LLC Celldex Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 500 shares of CLDX stock, worth $12,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$12,375
Previous $12,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
203Shares Held
68.3MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$151 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$130 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$97.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$94.5 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.16B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...